TrialBritish journal of cancer2022

Once weekly selinexor, carfilzomib and dexamethasone in carfilzomib non-refractory multiple myeloma patients.

Cristina Gasparetto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.